Humacyte, Inc. HUMA
0.44 USD +0.04 (+10.65%)
At closeNov 4, 2026, 4:43 AM EST
0.43 -0.01 -2.38%
Pre-market · Nov 4, 4:43 AM ET
0.391 Day range 0.4452
0.337 52-week range 1.56
- YTD
- -54.16%
- 1 year
- -72.30%
Financial health
Altman Z-Score
-8.67 Distress zone
Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.
Piotroski F-Score
3 / 9 Weak
Nine pass/fail tests of profitability, leverage and efficiency.
FMP rating
D+1 / 5 overall
- DCF 1
- Return on Equity 1
- Return on Assets 1
- Debt / Equity 1
- P/E 1
- P/B 1
Valuation
P/E -3.7×
FY 2019 5y median -4.0× FY 2025
P/S 74.5×
FY 2019 5y median 74.5× FY 2025
P/B 48.9×
FY 2019 5y median 2.4× FY 2025
P/FCF -1.4×
FY 2019 5y median -3.6× FY 2025
EV/EBITDA -7.5×
FY 2019 5y median -4.3× FY 2025
EV/Sales 81.6×
FY 2019 5y median 75.2× FY 2025
FCF Yield -69.7%
FY 2019 5y median -28.1% FY 2025
Profitability
Gross Margin -736.5%
FY 2019 5y median -427.5% FY 2025
Operating Margin -5271.7%
FY 2019 5y median -5271.7% FY 2025
Net Margin -2003.6%
FY 2019 5y median -764.5% FY 2025
ROE -1313.4%
FY 2019 5y median -21.7% FY 2025
ROIC -107.0%
FY 2019 5y median -89.1% FY 2025
ROA -35.1%
FY 2019 5y median -35.1% FY 2025
Growth (YoY)
Revenue 0.0%
FY 2019 FY 2025
Operating Income 6.1%
FY 2019 FY 2025
EPS (diluted) 79.4%
FY 2019 FY 2025
Free Cash Flow -6.3%
FY 2019 FY 2025
Financial Health
Current Ratio 3.7×
FY 2019 5y median 4.5× FY 2025
Quick Ratio 3.0×
FY 2019 5y median 4.5× FY 2025
Debt / Equity 20.9×
FY 2019 5y median 0.4× FY 2025
Net Debt / EBITDA -0.6×
FY 2019 5y median 0.2× FY 2025
Interest Coverage -9.5×
FY 2019 5y median -13.6× FY 2025
Dividends
Dividend Yield 0.0%
FY 2019 5y median 0.0% FY 2025
Payout Ratio 0.0%
FY 2019 5y median 0.0% FY 2025
Annual · latest fiscal year ends 2025-12-31